Supporting the

Neuroendocrine Cancer Community

Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

NICE Approve SIRT Therapy for neuroendocrine tumours 

NICE Approve SIRT Therapy for neuroendocrine tumours 

We are delighted to share with you the news that NICE has approved SIRT (selective internal radiation therapy) for the treatment of neuroendocrine tumour-related liver metastases.  NICE Interventional procedures guidance [IPG786]: Selective internal radiation therapy...

read more